People: NeuroMetrix Inc (NURO.W)
NURO.W on CBOE When Trading NASDAQ Global Select Market
2.04USD
13 Jun 2013
2.04USD
13 Jun 2013
Price Change (% chg)
$0.06 (+3.03%)
$0.06 (+3.03%)
Prev Close
$1.98
$1.98
Open
$2.04
$2.04
Day's High
$2.04
$2.04
Day's Low
$2.04
$2.04
Volume
100
100
Avg. Vol
19
19
52-wk High
$3.48
$3.48
52-wk Low
$1.87
$1.87
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Shai Gozani |
47 | 2008 | Chairman of the Board, President, Chief Executive Officer, Secretary |
Thomas Higgins |
60 | 2009 | Chief Financial Officer, Senior Vice President, Treasurer |
Krishnamurthy Balachandran |
53 | 2011 | Senior Vice President, Chief Operating Officer - Neurodiagnostics |
Michael Williams |
55 | 2011 | Senior Vice President - Engineering, Chief Technology Officer |
Guy Daniello |
67 | 2003 | Senior Vice President - Information Technology |
David Goodman |
55 | 2004 | Independent Director |
Allen Hinkle |
61 | 2006 | Independent Director |
Nancy Katz |
52 | 2010 | Independent Director |
Timothy Surgenor |
52 | 2009 | Independent Director |
Biographies
| Name | Description |
|---|---|
Shai Gozani |
Dr. Shai N. Gozani, M.D., Ph.D., is Chairman of the Board, President, Chief Executive Officer, Secretary of NeuroMetrix Inc. He founded company in 1996 and currently serves as Chairman of Board of Directors and as President, Chief Executive Officer and Secretary. Since founding company in 1996, Dr. Gozani has served in a number of positions at company including Chairman since 1996, President from 1996 to 1998 and from 2002 to the present, Chief Executive Officer since 1997 and Secretary since July 2008. Dr. Gozani holds a B.A. in computer science, an M.S. in Biomedical Engineering and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences at M.I.T. Prior to forming company, Dr. Gozani completed a neurophysiology research fellowship in the laboratory of Dr. Gerald Fischbach at Harvard Medical School. Dr. Gozani has published articles in the areas of basic and clinical neurophysiology, biomedical engineering and computational chemistry. The Board has concluded that Dr. Gozani should serve as a director because Dr. Gozani’s knowledge of engineering and neurophysiology, combined with the unique understanding of technology and business he has gained as founder and as a key executive, provides invaluable insight to Board and to the entire organization. |
Thomas Higgins |
Mr. Thomas T. Higgins is Chief Financial Officer, Senior Vice President, Treasurer of NeuroMetrix Inc. Prior to joining NeuroMetrix, from January 2005 to March 2008, Mr. Higgins was Executive Vice President and Chief Financial Officer at Caliper Life Sciences, Inc., a provider of technology and services for life sciences research. Before Caliper, Mr. Higgins was Executive Vice President, Operations and Chief Financial Officer at V.I. Technologies, Inc., (Vitex), a biotechnology company addressing blood safety. Before Vitex, Mr. Higgins served at Cabot Corporation in various senior finance and operations roles. His last position at Cabot was President of Distrigas of Massachusetts Corporation, a subsidiary involved in the liquefied natural gas business, and prior to that he was responsible for Cabot’s Asia Pacific carbon black operations. Before joining Cabot, Mr. Higgins was with PricewaterhouseCoopers where he started his career. Mr. Higgins holds a BBA with honors from Boston University. |
Krishnamurthy Balachandran |
Mr. Krishnamurthy Balachandran is Senior Vice President, Chief Operating Officer - Neurodiagnostics of NeuroMetrix Inc. He has served as Senior Vice President and General Manager, International since April 2010. In January 2011 he assumed additional responsibilities as Chief Operating Officer, Neurodiagnostics. Prior to joining NeuroMetrix, from November 2007 to April 2010, Mr. Balachandran was Vice President and General Manager of Cardinal Health’s NeuroCare Division, a provider of technology and services to the neurophysiology industry. Before joining Cardinal Health, Mr. Balachandran worked at with Hewlett Packard as Senior Director, Global Alliances from April 1999 to December 2006. Prior to joining Hewlett Packard, Mr. Balachandran was Vice President, International Sales and Marketing for Nicolet Biomedical, the business in EMG and nerve conduction testing which was subsequently acquired by Cardinal Health and became its NeuroCare division. Mr. Balachandran started his career in sales with Blue Star, Ltd of India. Mr. Balachandran, an electrical engineer from the National Institute of Technology in India, holds an MBA in Marketing from the Indian Institute of Management in Ahmedabad, India. |
Michael Williams |
Dr. Michael Williams, Ph.D., is Senior Vice President - Engineering, Chief Technology Officer of NeuroMetrix Inc. Prior to that time, as Senior Vice President of Engineering since July 2003 and as Vice President of Engineering since May 2000. From March 1996 to January 2000, Dr. Williams served as Division President at Radionics, where he was responsible for all software-based products, including treatment planning and image-guided surgery. Prior to Radionics, he served as an engineer at Hughes Aircraft Space & Communications Group. Dr. Williams received a B.S. in physics and mathematics from University of Puget Sound and an M.S. and Ph.D. in Physics from Brown University. |
Guy Daniello |
Mr. Guy Daniello is Senior Vice President - Information Technology of NeuroMetrix Inc. Prior to that time, as Vice President of Information Technology and Director of Information Technology since 1998. Prior to joining NeuroMetrix, Mr. Daniello was an independent software consultant, the Senior Vice President of Engineering at Shiva Corporation from 1996 to 1997, and the Chief Technology Officer and Vice President of Product Development at Gandalf Technologies from 1993 to 1996. In 1991 he founded Network Architects, a software company. Prior to starting Network Architects, he served as President and Chief Executive Officer of Datamedia Corp., and the Director of Small Systems Development at Honeywell Information Systems. Mr. Daniello holds a B.S. in business administration from Northeastern University. |
David Goodman |
Dr. David E. Goodman, M.D., is Independent Director of NeuroMetrix Inc. Dr. Goodman currently serves as an independent consultant and practicing physician. During 2010, Dr. Goodman has served as President and Chief Executive Officer of SEDline, Inc., a research-focused company with the mission to expand the scope and applications for neuromonitoring. From 2008 to 2009, Dr. Goodman served as Executive Vice President of Business Development for Masimo Corporation, a manufacturer of non-invasive patient monitors. From 2006 to 2008, Dr. Goodman served as an independent consultant providing product design, regulatory and analytical consulting services to medical device and biopharmaceutical companies and also served in this capacity from 2003 to 2004 and from 2001 to 2002. From 2005 to 2006, Dr. Goodman served as President and Chief Executive Officer of BaroSense, Inc., a medical device company focused on developing minimally invasive devices for the long-term treatment of obesity. From 2004 to 2005, Dr. Goodman served as President and Chief Executive Officer of Interventional Therapeutic Solutions, Inc., an implantable drug delivery systems company. From 2002 to 2003, Dr. Goodman served as Chairman, President and Chief Executive Officer of Pherin Pharmaceuticals, a pharmaceutical discovery and development company. From 1994 to 2001, Dr. Goodman held various positions, including Chief Executive Officer, Chief Medical Officer and director, for LifeMasters Supported SelfCare, Inc., a disease management services company that Dr. Goodman founded. Dr. Goodman also serves as a director of Sound Surgical Technologies LLC, a private manufacturer of aesthetic surgical tools. Dr. Goodman holds a B.A.S. in applied science and bioengineering and a M.S.E. in bioengineering from the University of Pennsylvania. He also received an M.D. from Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology. |
Allen Hinkle |
Dr. Allen J. Hinkle, M.D., is Independent Director of NeuroMetrix Inc. From December 2010 through the present, Dr. Hinkle has served as the Chief Medical Officer of MVP Health Care, a not-for-profit health insurer. Dr. Hinkle was the Chief Medical Officer and Senior Vice President for Tufts Health Plan in Massachusetts, a health insurance provider, where he was responsible for medical management programs and initiatives from 2004 to 2009. Prior to becoming the Chief Medical Officer of Tufts Health Plan, Dr. Hinkle was Senior Medical Director and Vice President of Health Care Quality, Policy and Innovations at Blue Cross Blue Shield of Massachusetts, a health insurance provider, from 2001 through September 2004. From 1995 to 2001, Dr. Hinkle was the Chief Medical Officer and Senior Vice President of Quality—Healthcare Management for Anthem Blue Cross Blue Shield of New Hampshire and Matthew Thornton Plan, health insurance provider organizations. Dr. Hinkle has over 30 years of experience in the healthcare field. Dr. Hinkle received a B.S. from the University of Massachusetts at Amherst and an M.D. from Albert Einstein College of Medicine in New York. He is board certified in pediatrics and anesthesiology and is an Associate Professor of Anesthesiology and Pediatrics at Dartmouth Medical School. He also owns several U.S. patents on medical devices. The Board has concluded that Dr. Hinkle should serve as a director because Dr. Hinkle’s years of experience as a physician and in executive positions in the health insurance industry provide the Board with insights in the areas of product development and reimbursement. |
Nancy Katz |
Ms. Nancy E. Katz is Independent Director of NeuroMetrix Inc. Since May 2011, Ms. Katz has served as Vice President, Consumer Marketing and Market Development at Medtronic, Inc., a medical technology company. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care—North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc, a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. She has previously served on the Boards of Directors of Neoprobe Corporation (AMEX: NEOP), Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. She received a B.S. in business from the University of South Florida. The Board has concluded that Ms. Katz should serve as a director because her experience in diabetes care and marketing into the diabetes sector provides insight to the Board and management in diabetes strategy. |
Timothy Surgenor |
Mr. Timothy R. Surgenor is Independent Director of NeuroMetrix Inc. Since April 2009, Mr. Surgenor has been a partner at Red Sky Partners, LLC, a provider of general management consulting services to the biotechnology and medical device industries. From 2003 to 2009, Mr. Surgenor served as President, Chief Executive Officer and director of Cyberkinetics Neurotechnology Systems (OTC: CYKN.PK), a medical device company. From January 1999 to January 2003, Mr. Surgenor was Executive Vice President at Haemonetics Corporation, which is a medical device company. From 1994 to 1999, Mr. Surgenor was President of Genzyme Tissue Repair, the cell therapy division of Genzyme Corporation. Previously, Mr. Surgenor was Executive Vice President and Chief Financial Officer of BioSurface Technology, Inc. and also held various positions in operations at Integrated Genetics. Mr. Surgenor received a B.A. in Biochemistry from Williams College and an M.B.A. from Harvard Business School. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Shai Gozani |
496,260 |
Thomas Higgins |
342,906 |
Krishnamurthy Balachandran |
348,730 |
Michael Williams |
286,091 |
Guy Daniello |
288,036 |
David Goodman |
-- |
Allen Hinkle |
-- |
Nancy Katz |
-- |
Timothy Surgenor |
-- |
As Of 30 Dec 2010
Options Compensation
| Name | Options | Value |
|---|---|---|
Shai Gozani |
375,000 | 1,406,250 |
Thomas Higgins |
0 | 0 |
Krishnamurthy Balachandran |
0 | 0 |
Michael Williams |
42,299 | 1,201,350 |
Guy Daniello |
50,515 | 932,202 |
David Goodman |
0 | 0 |
Allen Hinkle |
0 | 0 |
Nancy Katz |
0 | 0 |
Timothy Surgenor |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
GOODMAN DAVID E |
83 | $0.00 |
HINKLE ALLEN J |
83 | $0.00 |
KATZ NANCY E |
417 | $0.00 |
KATZ NANCY E |
84 | $1.90 |
HINKLE ALLEN J |
417 | $0.00 |
SURGENOR TIMOTHY R |
83 | $0.00 |
SURGENOR TIMOTHY R |
84 | $1.90 |
GOODMAN DAVID E |
417 | $0.00 |
HINKLE ALLEN J |
84 | $1.90 |
SURGENOR TIMOTHY R |
417 | $0.00 |
KATZ NANCY E |
83 | $0.00 |
GOODMAN DAVID E |
84 | $1.90 |
HIGGINS THOMAS T |
436 | $2.22 |
BALACHANDRAN KRISHNAMURTHY |
361 | $2.22 |
WILLIAMS MICHAEL L |
428 | $2.22 |
GOZANI SHAI N |
1,821 | $2.22 |
DANIELLO GUY A |
212 | $2.22 |
GOZANI SHAI N |
32,947 | $2.39 |
DANIELLO GUY A |
11,660 | $2.39 |
HIGGINS THOMAS T |
17,048 | $2.39 |
WILLIAMS MICHAEL L |
12,691 | $2.39 |
BALACHANDRAN KRISHNAMURTHY |
18,473 | $2.39 |
DANIELLO GUY A |
14 | $0.62 |
WILLIAMS MICHAEL L |
14 | $0.62 |
GOZANI SHAI N |
295 | $0.63 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
